Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A growing population of people living with advanced or metastatic cancer has raised questions about the unique needs of these individuals.
Patients with high-risk Stage II melanoma received Keytruda (pembrolizumab) after surgery to remove their original tumor.
Cancer research has seen enormous strides in the past 50 years, but disparities persist and COVID-19 has led to setbacks.
The MSNBC anchor revealed that she had surgery for skin cancer and made a passionate plea for everyone to get screened for the disease.
In early experiments, researchers found that “the antibiotics [could] buy the precious time needed for immunotherapy to kick in.”
Patricia Janiak learned how to ask the tough questions when her husband was diagnosed with mucosal melanoma.
At Melanoma Research Alliance’s 2021 Scientific Treat, scientists discussed enhancing anti-tumor immune response of combination therapies.
Opdivo plus relatlimab delayed disease progression compared with Opdivo alone.
Death rates for most cancers continue to decline.
Researchers provide updates on the clinical trial of a new drug to improve the long-term survival of patients facing advanced melanoma
Older individuals with a history of cancer experienced accelerated age-related functional decline.
At the “Surviving and Thriving Despite Melanoma” panel, experts discussed the emotional rollercoaster of living with melanoma
The American Academy of Dermatology designates the first Monday in May as Melanoma Monday.
May is National Melanoma/Skin Cancer Detection and Prevention Month.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.